SCHEMBL6963723

SCHEMBL6963723

COc1cccc(CCc2cc(C)ccc2S(=O)(O)=S)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
ABCB1 P08183 8/20 0.44
HTR1A P08908 2/20 0.44
DRD2 P14416 2/20 0.44
TAAR1 Q96RJ0 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
IDH1 O75874 1/20 0.42
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603746 0.91 IDH1 (0.45) IDH1MTNR1AMTNR1BALDH1A1SMN1; SMN2
SCHEMBL5950230 0.90 CHRM2 (0.47) CHRM2CHRM1CHRM3ABCB1HTR1A
SCHEMBL6967073 0.86 CALM1 (0.44) ALDH1A1SMN1; SMN2
SCHEMBL6604226 0.83 TDP1 (0.43) ALDH1A1SMN1; SMN2
SCHEMBL8993162 0.81 IDH1 (0.47) CHRM2CHRM1CHRM3IDH1MTNR1A
SCHEMBL6963726 0.78 CHRM2 (0.45) CHRM2CHRM1CHRM3ABCB1HTR1A
SCHEMBL17710449 0.77 CNR2 (0.45) ALDH1A1SMN1; SMN2
SCHEMBL6605222 0.76 MEN1 (0.45) IDH1ALDH1A1
SCHEMBL7492550 0.76 ABCB1 (0.49) ABCB1HTR1ADRD2TAAR1ABCG2
SCHEMBL6605337 0.76 ALDH1A1 (0.41) DRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed